Khameneh, Zakieh RostamzadehTaghizade-Afshari, AliMasudi, SimaSepehrvand, Nariman2025-12-232010-06Experimental and Clinical Transplantation, Cilt, 8, Sayı, 2, 2010 ss. 146-1491304-0855https://hdl.handle.net/11727/14229Background: Renal transplant recipients are susceptible to viral infections because of their immunocompromised background. HTLV-1 is a retrovirus that leads to adult T-cell leukemia/lymphoma or myelopathies. This study aimed to evaluate HTLV-1 antibodies among renal transplant recipients in Urmia, Iran. Materials and Methods: Serum samples of 91 renal transplant recipients from Urmia, Iran, were examined serologically for antibodies against HTLV type 1 using an enzyme-linked immunosorbent assay. Results: Mean age was 37.26 ± 14.22 years old. Only 1 patient had a positive anti-HTLV-1 enzyme-linked immunosorbent assay test, which was confirmed by Western blot. The HTLV-1–positive case did not have HTLV-associated clinical manifestation. This patient was a 45-year-old man, with no history of blood transfusion, but he did have a history of hemodialysis before transplant. Conclusions: The frequency of HTLV-1 among renal transplant recipients of our region in the northwest of Iran was not so high, and it is similar to the HTLV-1 seroprevalence among hemodialysis patients. Still, it is more frequent among healthy blood donors as representative of the general population in our region.en-USHuman T lymphocyte virus type 1Renal transplantELISAArticle822146-8427